Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2005
11/30/2005EP1599206A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
11/30/2005EP1599202A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/30/2005EP1599174A2 Novel compounds
11/30/2005EP1467996B1 Pyrimidotriazines as phosphatase inhibitors
11/30/2005EP1380295A4 Photosensitiser and method for production thereof
11/30/2005EP1280780B1 Asymmetric synthesis of piperazic acid and derivatives thereof
11/30/2005EP1071474B1 Substituted porphyrins
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1229382C Hemisynthetic method and intermediate thereof
11/30/2005CN1229378C Process for preparing pure triethylenediamine
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/30/2005CN1229349C Pyridine-3-carboxylic acid derivative
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/29/2005US6969767 5-(haloalkyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine; enzymatic process for intermediate's synthesis and transformation to (+)-zopiclone
11/29/2005US6969765 Photosensitizer and method for production thereof
11/29/2005US6969764 Optical recording medium and novel azaporphyrin compounds
11/29/2005US6969726 can be used as anti-proliferative agents and/or anti-infective agents that can be used without limitation as anti-inflammatory agents
11/29/2005US6969719 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
11/29/2005US6969717 Azaindole kinase inhibitors
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005US6969710 Compounds
11/29/2005US6969707 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage
11/29/2005CA2420329C Sulphonylaminocarbonyltriazolinones
11/29/2005CA2244245C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/24/2005WO2005111043A1 Method for producing a solution of pure triethylenediamine (teda)
11/24/2005WO2005111042A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005WO2005111041A1 Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation
11/24/2005WO2005111040A1 Pyrrolobenzimidazolones and their use as antiproliferative agents
11/24/2005WO2005111039A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
11/24/2005WO2005111038A2 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
11/24/2005WO2005111032A1 New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indl-2-one hydrochloride) and process to produce the same
11/24/2005WO2005111031A2 Neuropeptide receptor modulators
11/24/2005WO2005111022A1 Pyrimidines derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111020A2 Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by vla-4
11/24/2005WO2005111003A1 Amino-tetrazoles analogues and methods of use
11/24/2005WO2005110999A1 Novel imidazole derivatives, the production thereof, and the use of the same as intermediate products for producing medicaments and pesticides
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110989A1 Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
11/24/2005WO2005110984A1 Process for producing cyclic n-hydroxyimide compound
11/24/2005WO2005110982A2 Substituted 1-benzyl-4-substituted piperazine analogues
11/24/2005WO2005110415A1 Hiv integrase inhibitors
11/24/2005WO2005110414A2 Hiv integrase inhibitors
11/24/2005WO2005080396A3 Azolopyrimidine compounds and use thereof for combating parasitic fungi
11/24/2005WO2005076383A3 Phthalocyanine derivatives, their use as homeotropically aligned layer in electronic devices and method for the manufacturing thereof
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261495 Lactam Compound
11/24/2005US20050261491 Novel substituted calix (4) pyrroles and process for the synthesis of calix (4) pyrroles over molecular sieve catalysts
11/24/2005US20050261402 Containing one or more optionally oxidized phenylthio groups; block out a specific blue-tinged red shade with high transparency, are coloristically pure and are highly transparent; color filters
11/24/2005US20050261350 Pyrrolobenzimidazolones and their use as anti-proliferative agents
11/24/2005US20050261348 (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
11/24/2005US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia
11/24/2005US20050261327 2-(Bicyclo)alkylamino-derivatives as mediatores of chronic pain and inflammation
11/24/2005US20050261324 Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261322 HIV integrase inhibitors
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta
11/24/2005US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
11/24/2005US20050261314 7-Amino triazolopyrimidines for controlling harmful fungi
11/24/2005US20050261297 Compound for stimulating bone growth
11/24/2005US20050261296 Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261248 New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives
11/24/2005US20050260445 OLEDs utilizing macrocyclic ligand systems
11/24/2005US20050260128 Low toxicity carborane-containing 5, 10, 15, 20-tetraphenylporphyrin compounds; use in the treatment, visualization, and diagnosis of tumors such as in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT)
11/24/2005CA2566917A1 Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation
11/24/2005CA2566332A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005CA2565984A1 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/24/2005CA2565211A1 Amino-tetrazoles analogues and methods of use
11/24/2005CA2564751A1 Neuropeptide receptor modulators
11/24/2005CA2562857A1 Novel imidazole derivatives, the production thereof, and the use of the same as intermediate products for producing medicaments and pesticides
11/23/2005EP1598354A1 Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation
11/23/2005EP1598353A1 Pyrrolobenzimidazolones and their use as antiproliferative agents
11/23/2005EP1597261A1 Substituted amino heterocycles as vr-1 antagonists for treating pain
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/23/2005EP1597259A1 Nitrogen-substituted hexahydropyrazino 1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments
11/23/2005EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/23/2005EP1597215A1 Mono amine and diamine derivatives of cl-20
11/23/2005EP1343788B1 Imidazo-triazine derivatives as ligands for gaba receptors
11/23/2005EP1165071B1 Improved cancer treatment with temozolomide
11/23/2005EP0938474B1 Cyclopropylindole compounds and their use as prodrugs
11/23/2005CN1701074A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/23/2005CN1701073A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/23/2005CN1701069A 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
11/23/2005CN1228339C Method for selectively synthesizing triethylenediamine
11/22/2005US6967215 Suitable for disinfection, deodorisation, and for the general and antimicrobial treatment of the skin and mucosa, and integumentary appendages (hair), especially for the disinfection of hands and wounds
11/22/2005US6967204 Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors
11/22/2005US6967200 Remedies for cirrhosis
11/22/2005US6967198 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
11/22/2005US6967079 Pyrimidine derivatives for labeled binding partners
11/22/2005CA2181553C Pyrrolopyridazine derivatives
11/17/2005WO2005108402A1 3,6-diazabicyclos[3.1.1]heptane derivatives with analgesic activity
11/17/2005WO2005108401A1 2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]methanones
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005107760A1 Compounds and compositions as inducers of keratinocyte differentiation
11/17/2005WO2005085177A3 Biaryl amino acids and their use in dna binding oligomers
11/17/2005WO2005072361A3 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
1 ... 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 ... 573